Related Experiment Video
Updated: Feb 16, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant
Yusuke Takayama1, Tetsuya Kubota1, Yoshitaka Ogino1
1Department of Hematology and Respiratory Medicine, Kochi Medical School, Kochi University, Japan.
Abstract:
TAFRO syndrome is a systemic inflammatory disorder that is characterized by thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly. Although thrombocytopenia is one of the major features of TAFRO syndrome, complications of disseminated intravascular coagulation (DIC) are not common. The therapeutic strategy for TAFRO syndrome complicated by DIC has not been established. We herein describe a case of TAFRO syndrome with DIC that was successfully treated with tocilizumab (an anti-IL-6 receptor antibody) and recombinant thrombomodulin (rTM). This case suggests a possible therapeutic benefit of rTM in patients with TAFRO syndrome complicated by DIC.
Related Concept Videos
Coagulation
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Recombinant DNA
Viral Recombination
Homologous Recombination
Overview of Transposition and Recombination

